Article

(2024) Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements. Molecular Biotechnology. ISSN 10736085 (ISSN)

(2023) Biomimetic Nanovaccines: A Novel Approach in Immunization. Current pharmaceutical design. pp. 1391-1408. ISSN 1381-6128

(2023) Macrophage efferocytosis in health and disease. Cell Biochemistry and Function. pp. 152-165. ISSN 0263-6484

(2023) The Regulation, Functions, and Signaling of miR-153 in Neurological Disorders, and Its Potential as a Biomarker and Therapeutic Target. Current Molecular Medicine. pp. 863-875. ISSN 1566-5240

(2023) Understanding the regulation of "Don't Eat-Me" signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy. Journal of Cancer Research and Clinical Oncology. pp. 511-529. ISSN 0171-5216

(2022) Potential diagnostic and prognostic of efferocytosis-related unwanted soluble receptors/ligands as new non-invasive biomarkers in disorders: a review. Molecular Biology Reports. pp. 5133-5152.

(2022) Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions. Pharmacology and Therapeutics.

(2022) The regulation of efferocytosis signaling pathways and adipose tissue homeostasis in physiological conditions and obesity: Current understanding and treatment options. Obesity Reviews.

(2022) The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target. Medical Oncology.

(2021) Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons. Advances in Experimental Medicine and Biology. pp. 63-78.

(2021) Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks. European Journal of Pharmacology.

(2021) Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view. International Immunopharmacology.

(2021) COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Review of Anti-Infective Therapy. pp. 345-357.

(2021) The Effect of Cigarette Smoke Exposure on Efferocytosis in Chronic Obstructive Pulmonary Disease; Molecular Mechanisms and Treatment Opportunities. Copd-Journal of Chronic Obstructive Pulmonary Disease. pp. 723-736. ISSN 1541-2555

(2021) Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon.

(2021) Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens. Recent patents on biotechnology. pp. 112-136. ISSN 2212-4012 (Electronic) 1872-2083 (Linking)

(2021) The complex roles of efferocytosis in cancer development, metastasis, and treatment. Biomedicine and Pharmacotherapy.

(2021) The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy? Molecular Biology Reports. pp. 5707-5722.

(2021) The significant role of a functional polymorphism in the NF-κB1 gene in breast cancer: evidence from an Iranian cohort. Future Oncology. pp. 4895-4905.

(2015) Association of tumor necrosis factor-alpha promoter G-308A gene polymorphism with increased triglyceride level of subjects with metabolic syndrome. Gene. pp. 81-4. ISSN 1879-0038 (Electronic) 0378-1119 (Linking)